Profil
Cole Ikkala is currently the Head of Business Operations for the Neuroscience Group at Radius Health, Inc. Prior to this, he worked as the Director of Investor Relations and Communications at NVN Liquidation, Inc.
Postes actifs de Cole Ikkala
| Sociétés | Poste | Début |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/07/2020 |
Anciens postes connus de Cole Ikkala
| Sociétés | Poste | Fin |
|---|---|---|
| NVN LIQUIDATION, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
